Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > OT: Details behind $5.7B Danaher acquisition of Abcam
View:
Post by Noteable on Oct 11, 2023 12:03pm

OT: Details behind $5.7B Danaher acquisition of Abcam

UK-based Abcam revealed more details behind its $5.7 billion acquisition by Danaher, including the dozens of potential buyers the company engaged with as well as internal and external turmoil with Abcam’s founder and former CEO Jonathan Milner over the performance of the company, the makeup of the board and the deal with Danaher.

https://otp.investis.com/clients/uk/abcamplc2/sec/sec-show.aspx?Type=html&FilingId=16974085&CIK=0001492074&Index=10000#d878585dex991_htm
Comment by fox7mf on Oct 11, 2023 1:10pm
Thanks for the informative posts Note, but i can't be the only one fed up with reading about every biotech not Oncy getting snatched up, right? I don't think many can preach patience to Oncy investors without being laughed outta the room. The SP languishes...the management underwhelms.
Comment by Angler101 on Oct 11, 2023 1:21pm
Foxy....I think the point Notable was trying to show is that Matt has stated they are in discussions with more than one BP......and none of us knows how complicated those discussions are or how long it might take to make a deal.....I know if I was selling a boat and instead of one buyer, there were 8 or more standing there making offers on it, I’d wanna take a little more time before settling on ...more  
Comment by Angler101 on Oct 11, 2023 1:27pm
After all.... that is his duty to shareholders....to take a little time to get the right offer, not just jump at the first one or two that get thrown out there......
Comment by fox7mf on Oct 11, 2023 2:12pm
We all know what his duty is, thanks, and he has yet to do anything to create shareholder value. Coffey has a lot to do to instill any shareholder faith, and that starts and ends with a lucrative partnership or buyout. We'll see what ESMO brings, but I'm not expecting the SP to rocket on anything less than the aforementioned. My opinion. 
Comment by Angler101 on Oct 11, 2023 3:32pm
Well, Fox, a lucrative partnership or buyout is only going to happen when Matt, the board of directors and the ceos and legal teams from 6 or 7 or maybe 10 or more multi billion dollar pharmas figure it all out and I think that’s going to take a little more time than you might like...
Comment by fox7mf on Oct 11, 2023 4:25pm
The PanCan agreement may be an indication of the lack of BP interest. We'll hopefully soon see.
Comment by jh1970 on Oct 11, 2023 4:56pm
I have a similar feelings. If is so good why share price is so bad.
Comment by JohnnyYeg on Oct 11, 2023 7:00pm
Anything is possible I will concede, but that's stretching it a bit Foxy.... ;)
Comment by fox7mf on Oct 11, 2023 7:43pm
I know buddy, I'm poopy today...just want/need things to finally move on up for ONCY!!!! Good luck with your Oilers tonight!!
Comment by Buckhenry on Oct 11, 2023 2:11pm
If unnoteable didn't talk about all the other companies Being bought out what would he talk sbout?  This makes us all feel all gitty that we bought a dog.... oh... and please be patient.  
Comment by Azzak34 on Oct 11, 2023 2:13pm
I feel like that last post was some sort of code. It was English but it's not clear. 
Comment by Noteable on Oct 11, 2023 2:28pm
Codebreaker. ONCY is not a lifescience supply company and consequently is worth much more.
Comment by Noteable on Oct 11, 2023 1:29pm
Abcam Plc , is a provider of supplies to life science researchers and does not have any biopharmaceutical drug products.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities